Cargando…
An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240078/ https://www.ncbi.nlm.nih.gov/pubmed/34187499 http://dx.doi.org/10.1186/s12992-021-00713-4 |
_version_ | 1783715144983904256 |
---|---|
author | Jailobaeva, Kanykey Falconer, Jennifer Loffreda, Giulia Arakelyan, Stella Witter, Sophie Ager, Alastair |
author_facet | Jailobaeva, Kanykey Falconer, Jennifer Loffreda, Giulia Arakelyan, Stella Witter, Sophie Ager, Alastair |
author_sort | Jailobaeva, Kanykey |
collection | PubMed |
description | BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral, multilateral, and not-for-profit organisations) have been understudied. METHODS: This study aimed to map the key global actors investing in action regarding NCDs and review their policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy papers was completed, and related to data collated from the Global Health Data Visualisation Tool. RESULTS: In 2019 41% of development assistance for health committed to NCDs came from private philanthropies, while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within bilateral portfolios – receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however, funding allocations are not aligned. CONCLUSION: The growing threat of NCDs and their drivers are increasingly recognised. However, global actors’ policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their investment and engagement, more research is needed into the role of private philanthropies and NGOs in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00713-4. |
format | Online Article Text |
id | pubmed-8240078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82400782021-06-29 An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries Jailobaeva, Kanykey Falconer, Jennifer Loffreda, Giulia Arakelyan, Stella Witter, Sophie Ager, Alastair Global Health Research BACKGROUND: Noncommunicable diseases (NCDs), including mental health, have become a major concern in low- and middle-income countries. Despite increased attention to them over the past decade, progress toward addressing NCDs has been slow. A lack of bold policy commitments has been suggested as one of the contributors to limited progress in NCD prevention and management. However, the policies of key global actors (bilateral, multilateral, and not-for-profit organisations) have been understudied. METHODS: This study aimed to map the key global actors investing in action regarding NCDs and review their policies to examine the articulation of priorities regarding NCDs. Narrative synthesis of 70 documents and 31 policy papers was completed, and related to data collated from the Global Health Data Visualisation Tool. RESULTS: In 2019 41% of development assistance for health committed to NCDs came from private philanthropies, while that for other global health priorities from this source was just 20%. Through a range of channels, bilateral donors were the other major source of NCD funding (contributing 41% of NCD funding). The UK and the US were the largest bilateral investors in NCDs, each contributing 8%. However, NCDs are still under-prioritised within bilateral portfolios – receiving just 0.48% of US funding and 1.66% of the UK. NGOs were the key channels of funding for NCDs, spending 48% of the funds from donors in 2019. The reviewed literature generally focused on NCD policies of WHO, with policies of multilateral and bilateral donors given limited attention. The analysis of policies indicated a limited prioritisation of NCDs in policy documents. NCDs are framed in the policies as a barrier to economic growth, poverty reduction, and health system sustainability. Bilateral donors prioritise prevention, while multilateral actors offer policy options for NCD prevention and care. Even where stated as a priority, however, funding allocations are not aligned. CONCLUSION: The growing threat of NCDs and their drivers are increasingly recognised. However, global actors’ policy priorities and funding allocations need to align better to address these NCD threats. Given the level of their investment and engagement, more research is needed into the role of private philanthropies and NGOs in this area. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12992-021-00713-4. BioMed Central 2021-06-29 /pmc/articles/PMC8240078/ /pubmed/34187499 http://dx.doi.org/10.1186/s12992-021-00713-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jailobaeva, Kanykey Falconer, Jennifer Loffreda, Giulia Arakelyan, Stella Witter, Sophie Ager, Alastair An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title | An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title_full | An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title_fullStr | An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title_full_unstemmed | An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title_short | An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
title_sort | analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240078/ https://www.ncbi.nlm.nih.gov/pubmed/34187499 http://dx.doi.org/10.1186/s12992-021-00713-4 |
work_keys_str_mv | AT jailobaevakanykey ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT falconerjennifer ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT loffredagiulia ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT arakelyanstella ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT wittersophie ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT ageralastair ananalysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT jailobaevakanykey analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT falconerjennifer analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT loffredagiulia analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT arakelyanstella analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT wittersophie analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries AT ageralastair analysisofpolicyandfundingprioritiesofglobalactorsregardingnoncommunicablediseaseinlowandmiddleincomecountries |